Definition
Inflammatory Bowel Disease (IBD) refers to a group of chronic, immune-mediated disorders that cause persistent inflammation of the gastrointestinal (GI) tract. The two primary types are:
- Crohn’s disease: Can affect any part of the GI tract from the mouth to the anus. Inflammation may be patchy (“skip lesions”) and extend through all layers of the bowel wall, leading to strictures, fistulas, and deep ulcerations.
- Ulcerative colitis: Affects only the colon and rectum, with continuous inflammation beginning in the rectum and extending proximally. Damage is limited to the mucosal and submucosal layers.
IBD is not the same as Irritable Bowel Syndrome (IBS) — IBS is a functional disorder without inflammation or tissue damage. IBD causes visible inflammation, confirmed by biopsy, and often leads to structural changes in the bowel.
The condition is lifelong, with alternating periods of flare-ups and remission. It often begins in adolescence or young adulthood, but can appear at any age.
- Access & outcomes: Minority patients (Black, Hispanic, Asian) face delays in diagnosis, less specialist access, and lower rates of long-term management care
- Hospitalization differences: Black patients with IBD are more likely to visit ER or rely on steroids; length of hospital stays varies significantly by race (e.g., average 11.1 days for Asian patients vs 8 for White patients)
- Solutions: Telemedicine, biosimilars, diverse care teams, and affordability-focused interventions may help bridge gaps
Symptoms
IBD symptoms vary depending on whether the person has Crohn’s disease or ulcerative colitis, the location of inflammation, and whether the disease is active (flare) or inactive (remission).
- Digestive symptoms
- Persistent diarrhea, sometimes urgent or bloody
- Abdominal pain and cramping
- A frequent need to pass stool, sometimes at night
- Mucus in the stool
- Rectal bleeding (more common in ulcerative colitis)
- In Crohn’s disease, deep ulcers, fistulas, or strictures that may cause bowel blockages
- Whole-body symptoms
- Fatigue and low energy
- Loss of appetite and unintentional weight loss
- Anemia from chronic bleeding or poor nutrient absorption
- In children and teens
- Delayed growth or delayed puberty
- Extraintestinal (outside the gut) symptoms
- Joint pain or arthritis
- Skin issues such as erythema nodosum (red, tender bumps) or pyoderma gangrenosum (painful ulcers)
- Eye inflammation like uveitis
- Liver problems, including primary sclerosing cholangitis
- Bone loss (osteoporosis), especially with long-term steroid use
- Flares and remissions
- Symptoms tend to come and go. In a flare, they may be severe and disruptive.
- In remission, symptoms improve or disappear, but inflammation may still be present.
- Triggers for flare-ups
- Infections, certain medications (like NSAIDs or antibiotics), high stress, dietary changes, or stopping prescribed medicines can bring symptoms back.
Causes
The exact cause of inflammatory bowel disease (IBD) is not fully understood, but most experts believe it comes from a combination of immune system problems, genetic risk factors, environmental triggers, and changes in the gut microbiome. These factors may interact in different ways for each person.
- Immune system overreaction – In IBD, the immune system mistakenly attacks harmless substances in the digestive tract, such as food particles or normal gut bacteria, causing chronic inflammation.
- Genetic predisposition – People with a close family member who has IBD (Crohn’s disease or ulcerative colitis) have a much higher risk. Dozens of genetic variants linked to immune function and gut barrier health have been associated with the disease.
- Environmental triggers – Infections of the gut, particularly in early life, may increase the risk. Other triggers include:
- Western-style diets high in processed food and low in fiber
- Smoking (especially for Crohn’s disease)
- Frequent use of NSAIDs like ibuprofen
- Air pollution or exposure to industrial chemicals
- Gut microbiome changes – People with IBD often have less diversity in their gut bacteria and more microbes that promote inflammation.
- Stress and diet effects – While stress and certain foods do not directly cause IBD, they can trigger flares or worsen symptoms in people who already have it.
Diagnosis
There is no single test that can diagnose IBD. Doctors use a combination of medical history, physical examination, laboratory tests, imaging, and endoscopic evaluation to distinguish IBD from other digestive conditions such as irritable bowel syndrome (IBS), infections, or colorectal cancer.
1. Medical History & Physical Examination
Your gastroenterologist will start with:
- Symptom history:
- Onset and duration of diarrhea, abdominal pain, rectal bleeding, urgency, weight loss, or fatigue
- Flare and remission patterns
- Any triggers (diet, stress, medications)
- Family history: Relatives with IBD, celiac disease, colorectal cancer, autoimmune disorders
- Lifestyle factors: Smoking (worsens Crohn’s), NSAID use, travel history
- Extraintestinal symptoms: Joint pain, eye inflammation, skin rashes, mouth ulcers
- Physical exam:
- Abdominal tenderness or masses
- Signs of anemia (pale skin)
- Weight and growth charting (especially in children)
2. Laboratory (Blood) Tests
Blood work helps detect inflammation, nutritional deficiencies, and rule out other causes.
- Inflammatory markers:
- C-reactive protein (CRP) — elevated during active inflammation
- Erythrocyte sedimentation rate (ESR) — slower to respond but useful for trends
- Complete blood count (CBC):
- Low hemoglobin = anemia from bleeding or poor absorption
- Elevated white blood cells = possible inflammation or infection
- Nutritional status:
- Low albumin, iron, vitamin B12, vitamin D, or folate suggest malabsorption
- Liver function tests:
- Detect complications like primary sclerosing cholangitis (PSC)
- Antibody tests (less common): pANCA and ASCA can help differentiate Crohn’s from ulcerative colitis but aren’t definitive.
Used to detect inflammation in the intestines and rule out infections.
- Fecal calprotectin: Protein released by white blood cells during intestinal inflammation; high levels suggest IBD rather than IBS.
- Fecal lactoferrin: Similar to calprotectin, another marker of inflammation.
- Stool cultures: Rule out infections like Salmonella, Shigella, Campylobacter, C. difficile, parasites.
4. Endoscopic Procedures
Direct visualization of the intestinal lining is the gold standard for diagnosing IBD.
- Colonoscopy (most common):
- Examines the entire colon and end of the small intestine (terminal ileum)
- Allows tissue biopsy to confirm diagnosis and distinguish Crohn’s from ulcerative colitis
- Reveals ulcers, strictures, inflammation pattern (continuous in UC, patchy in Crohn’s)
- Flexible sigmoidoscopy:
- Looks at the rectum and lower colon
- Used when colonoscopy isn’t possible (severe inflammation, urgent situations)
5. Imaging Studies
Imaging helps assess disease location, extent, and complications not visible on colonoscopy.
- CT enterography: Detailed cross-sectional images of the bowel; detects strictures, abscesses, fistulas.
- MR enterography:
- Preferred for younger patients to avoid radiation
- Excellent for small bowel involvement and soft tissue detail
- Ultrasound (in some countries):
- Detects bowel wall thickening and inflammation
6. Capsule Endoscopy
- Patient swallows a pill-sized camera that takes thousands of pictures through the digestive tract.
- Especially useful for small bowel Crohn’s disease when other tests are inconclusive.
- Not recommended if strictures are suspected (risk of capsule getting stuck).
7. Differential Diagnosis
Your doctor will rule out:
- Irritable bowel syndrome (IBS)
- Infectious colitis
- Celiac disease
- Ischemic colitis
- Colon cancer
8. Disease Severity Assessment
Once IBD is confirmed, doctors classify its severity to guide treatment:
- Mild, moderate, or severe based on:
- Frequency of bowel movements
- Presence of blood
- Weight loss
- Laboratory and endoscopic findings
9. Ongoing Monitoring
Diagnosis is not a one-time event — regular testing helps track disease activity and treatment effectiveness.
- Repeat colonoscopies for cancer surveillance (every 1–2 years after 8 years of disease affecting the colon)
- Periodic blood and stool tests to monitor inflammation and nutrition
- Imaging when symptoms suggest complications
Treatment
There is currently no cure for Inflammatory Bowel Disease, but treatment can control inflammation, reduce symptoms, prevent complications, and maintain remission (periods without active disease).
Your gastroenterologist will create an individualized treatment plan based on:
- Type of IBD (Crohn’s disease or ulcerative colitis)
- Location and extent of inflammation
- Disease severity (mild, moderate, severe)
- How you respond to previous treatments
- Presence of complications
- Your age, lifestyle, and personal treatment preferences
1. Medicines
Most people with IBD need long-term medication to control the immune system’s overreaction in the gut. These medicines can be grouped by purpose:
A. Aminosalicylates (5-ASA drugs)
- Examples: Mesalamine, sulfasalazine, balsalazide, olsalazine
- Purpose: Reduce inflammation in the lining of the intestines, especially useful in ulcerative colitis.
- Forms: Oral tablets/capsules, enemas, suppositories.
- Common side effects: Headache, nausea, diarrhea, rash.
- Monitoring: Regular kidney and liver function tests.
B. Corticosteroids (steroids)
- Examples: Prednisone, budesonide, hydrocortisone
- Purpose: Powerful anti-inflammatory effect during flares, not for long-term maintenance because of side effects.
- Forms: Oral pills, IV, enemas, suppositories.
- Short-term side effects: Mood swings, weight gain, acne, insomnia.
- Long-term risks: Osteoporosis, high blood pressure, cataracts, diabetes.
- Tip: Doctors taper the dose slowly to prevent withdrawal symptoms.
C. Immunomodulators
- Examples: Azathioprine, 6-mercaptopurine (6-MP), methotrexate
- Purpose: Suppress the immune system to prevent inflammation over time; often used if 5-ASA or steroids aren’t enough.
- Time to work: Several weeks to months.
- Monitoring: Regular blood tests for liver function and white blood cell counts.
- Risks: Increased risk of infections, liver inflammation, rarely certain cancers.
D. Biologic Therapies
- Examples:
- Anti-TNF drugs: Infliximab, adalimumab, certolizumab pegol, golimumab
- Anti-integrin drugs: Vedolizumab
- Anti-IL-12/23 drugs: Ustekinumab
- Purpose: Target specific proteins in the immune system to block inflammation.
- How given: IV infusions or self-injections at set intervals.
- Benefits: Often effective when other medicines fail; can help close fistulas in Crohn’s.
- Risks: Higher risk of infections, infusion reactions, rare neurological or liver side effects.
- Pre-treatment checks
